Back

Treating underlying conditions improves quality of life in patients with persistent atrial fibrillation and heart failure - data from the RACE 3 study

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Mechanisms and outcomes in atrial fibrillation Atrial Fibrillation - Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Ruben De With

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Characteristics and outcomes of atrial fibrillation in patients without conventional risk factors: A RE-LY AF registry analysis
Professor I. Van Gelder (Groningen, NL)
Abstract Slides
Presentation thumbnail
Succses of atrial fibrillation ablation in patients with paroxsysmal or persistent AF when comparing continuous with periodic discontinuous continuous follow-up
Doctor U. Richter (Chemnitz, DE)
Abstract Slides
Presentation thumbnail
Atrial Fibrillation and Dementia in the Oldest Old: An Analysis from the Population-Based Study 'Monzino-80 Plus'
Doctor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Atrial fibrillation: 10 - year trends in epidemiology and prognosis for patients hospitalized in the Silesia region
Doctor P. Buchta (Riesa, DE)
Abstract Slides
Presentation thumbnail
Aetiology-dependent atrial vulnerability - systematic analyses of molecular atrial changes from different disease models
Doctor A. Bukowska (Magdeburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms and outcomes in atrial fibrillation

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources